Comparison between melanoma gene expression score and fluorescence in situ hybridization for the classification of melanocytic lesions

No abstract is available for this paper.

• Publication year

  2016

• Venue

  Modern Pathology

• Publication date

  2016-08-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1038/modpathol.2016.84PMID 27174586
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• A CLINICALLY VALIDATED GENE EXPRESSION SCORE IMPACTS DIAGNOSIS AND MANAGEMENT RECOMMENDATIONS OF MELANOCYTIC LESIONS BY DERMATOPATHOLOGISTS

  2015cited by this paper
• Clinical validation of a gene expression signature that differentiates benign nevi from malignant melanoma

  2015cited by this paper
• Cancer statistics, 2015

  2015cited by this paper
• Fluorescence In Situ Hybridization as an Ancillary Tool in the Diagnosis of Ambiguous Melanocytic Neoplasms: A Review of 804 Cases

  2014cited by this paper
• Ambiguous Melanocytic Tumors in a Tertiary Referral Center: The Contribution of Fluorescence In Situ Hybridization (FISH) to Conventional Histopathologic and Immunophenotypic Analyses

  2013cited by this paper
• Cytogenetic and mutational analyses of melanocytic tumors.

  2012cited by this paper
• Fluorescence in situ hybridization for ambiguous melanocytic tumors.

  2012cited by this paper
• Correlation between histologic assessment and fluorescence in situ hybridization using MelanoSITE in evaluation of histologically ambiguous melanocytic lesions.

  2012cited by this paper
• A Highly Specific and Discriminatory FISH Assay for Distinguishing Between Benign and Malignant Melanocytic Neoplasms

  2012cited by this paper
• Melanocytic Nevi With An Atypical Epithelioid Cell Component: Clinical, Histopathologic, and Fluorescence In Situ Hybridization Findings

  2011cited by this paper
• Fluorescence in situ hybridization, a diagnostic aid in ambiguous melanocytic tumors: European study of 113 cases

  2011cited by this paper
• Atypical Spitzoid melanocytic tumors: a morphological, mutational, and FISH analysis.

  2011cited by this paper
• FISH as an effective diagnostic tool for the management of challenging melanocytic lesions

  2011cited by this paper
• Fluorescence in situ hybridization for distinguishing cellular blue nevi from blue nevus‐like melanoma

  2011cited by this paper
• Use of Fluorescence In situ Hybridization (FISH) to Distinguish Intranodal Nevus From Metastatic Melanoma

  2010cited by this paper
• Classifying ambiguous melanocytic lesions with FISH and correlation with clinical long-term follow up

  2010cited by this paper
• Sensitivity of fluorescence in situ hybridization for melanoma diagnosis using RREB1, MYB, Cep6, and 11q13 probes in melanoma subtypes.

  2010cited by this paper
• Distinction of conjunctival melanocytic nevi from melanomas by fluorescence in situ hybridization

  2010cited by this paper
• Fluorescence in situ hybridization as a tool for microstaging in malignant melanoma

  2009cited by this paper
• Distinguishing Epithelioid Blue Nevus From Blue Nevus-like Cutaneous Melanoma Metastasis Using Fluorescence In Situ Hybridization

  2009cited by this paper
• Fluorescence In Situ Hybridization (FISH) as an Ancillary Diagnostic Tool in the Diagnosis of Melanoma

  2009cited by this paper
• Discordance in the histopathologic diagnosis of difficult melanocytic neoplasms in the clinical setting

  2008cited by this paper
• Interobserver Reproducibility of Histopathologic Prognostic Variables in Primary Cutaneous Melanomas

  2003cited by this paper
• Pathology review of cases presenting to a multidisciplinary pigmented lesion clinic.

  2002cited by this paper
• Interobserver variability on the histopathologic diagnosis of cutaneous melanoma and other pigmented skin lesions.

  1996cited by this paper
• Intermediate, Indeterminate, and Uninterpretable Diagnostic Test Results

  1987cited by this paper

• Ancillary Molecular Tests for the Diagnosis of Melanocytic Tumors

  2026cites this paper
• Predicting the S. cerevisiae Gene Expression Score by a Machine Learning Classifier

  2025cites this paper
• Assessing spatial sequencing and imaging approaches to capture the molecular and pathological heterogeneity of archived cancer tissues

  2025cites this paper
• Evaluating the Diagnostic Concordance of MyPath Melanoma Assay and PRAME Immunohistochemistry in Challenging Melanocytic Lesions.

  2025cites this paper
• A clinical impact study of dermatologists' use of diagnostic gene expression profile testing to guide patient management

  2024cites this paper
• Appropriate Statistical Methods to Assess Cross-study Diagnostic 23-Gene Expression Profile Test Performance for Cutaneous Melanocytic Neoplasms

  2024cites this paper
• Real World Validation of an Adjunctive Gene Expression Profiling Assay for Melanoma Diagnosis and Correlation with Clinical Outcomes at an Academic Center.

  2023cites this paper
• A Comparison of Preferentially Expressed Antigen in Melanoma Immunohistochemistry and Diagnostic Gene Expression-Profiling Assay in Challenging Melanocytic Proliferations

  2023cites this paper
• Advances in melanoma: epidemiology, diagnosis, and prognosis

  2023cites this paper
• AGAP2-AS1 affects TNM staging and prognosis of lung cancer patients by acting on SLC7A11 mRNA stability and ferroptosis

  2023cites this paper
• Ancillary testing for melanoma: current trends and practical considerations.

  2023cites this paper
• A Physician's Guide to the Use of Gene Expression Profile Ancillary Diagnostic Testing for Cutaneous Melanocytic Neoplasms.

  2023cites this paper
• Benchmarking robust spatial transcriptomics approaches to capture the molecular landscape and pathological architecture of archived cancer tissues

  2023cites this paper
• Malignant melanoma test results by a commercial 35‐gene expression test are enriched for benign or atypical Spitz tumors

  2022cites this paper
• Molecular testing in melanoma for the surgical pathologist.

  2022cites this paper
• lncRNA AGAP2-AS1 Facilitates Tumorigenesis and Ferroptosis Resistance through SLC7A11 by IGF2BP2 Pathway in Melanoma

  2022cites this paper
• Pitfalls in Cutaneous Melanoma Diagnosis and the Need for New Reliable Markers

  2022cites this paper
• Investigation of PRAME expression in lipid‐laden and non‐lipid‐laden cutaneous histiocytes

  2022cites this paper
• Dermatologic Disease-Directed Targeted Therapy (D3T2): The Application of Biomarker-Based Precision Medicine for the Personalized Treatment of Skin Conditions—Precision Dermatology

  2022cites this paper
• Clinical Use of a Diagnostic Gene Expression Signature for Melanocytic Neoplasms.

  2021cites this paper
• Practical Manual for Dermatologic and Surgical Melanoma Management

  2021cites this paper
• Molecular testing for melanocytic tumors: a practical update

  2021cites this paper
• Management of Transected Invasive Melanoma: A Single Institution Retrospective Review

  2021cites this paper
• Amelanotic metastatic gastric malignant melanoma: a case report

  2021cites this paper
• Molecular Biomarkers for Melanoma Screening, Diagnosis and Prognosis: Current State and Future Prospects

  2021cites this paper
• Concordance Analysis of the 23-Gene Expression Signature (myPath Melanoma) With Fluorescence In Situ Hybridization Assay and Single Nucleotide Polymorphism Array in the Analysis of Challenging Melanocytic Lesions: Results From an Academic Medical Center.

  2020cites this paper
• Gene Expression Profiling for Melanoma

  2020cites this paper
• MicroRNA ratios distinguish melanomas from nevi.

  2020cites this paper
• Updates on molecular diagnostic assays in melanocytic pathology

  2020cites this paper
• Targeted next generation sequencing (NGS) to classify melanocytic neoplasms

  2020cites this paper
• Technological advances for the detection of melanoma: Part II. Advances in molecular techniques.

  2020cites this paper
• Without Missing a Beat: Absence of Cilia Informs the Diagnosis of Histopathologically Challenging Spitzoid Melanocytic Neoplasms.

  2020cites this paper
• Clinical validity of a gene expression signature in diagnostically uncertain neoplasms.

  2020cites this paper
• PRAME expression in 155 cases of metastatic melanoma

  2020cites this paper
• The Laboratory Evaluation of Melanoma

  2020cites this paper
• PRAME immunohistochemistry as an adjunct for diagnosis and histological margin assessment in lentigo maligna

  2020cites this paper
• Development and Validation of a Diagnostic 35-Gene Expression Profile Test for Ambiguous or Difficult-to-Diagnose Suspicious Pigmented Skin Lesions

  2020influential citation
• Gene Expression Profiling for Melanoma

  2020cites this paper
• Gene Expression Profiling for Melanoma

  2020cites this paper
• CRTC1‐TRIM11 fusion defined melanocytic tumors: A series of four cases

  2019cites this paper
• Molecular Diagnostics in Melanocytic Neoplasia

  2019cites this paper
• Molecular testing of borderline cutaneous melanocytic lesions: SNP array is more sensitive and specific than FISH.

  2019cites this paper
• Vulvar Melanocytic Lesions

  2019cites this paper
• Applications of fluorescence in situ hybridization in detection of disease biomarkers and personalized medicine

  2019cites this paper
• Appropriate use criteria in dermatopathology: Initial recommendations from the American Society of Dermatopathology

  2019cites this paper
• A diagnostically‐challenging case of melanoma ex blue nevus with comprehensive molecular analysis, including the 23‐gene expression signature (myPath melanoma)

  2019cites this paper
• Pathologic analysis of melanocytic neoplasms.

  2018cites this paper
• Evidence behind the use of molecular tests in melanocytic lesions and practice patterns of these tests by dermatopathologists

  2018cites this paper
• Comparison of melanoma gene expression score with histopathology, fluorescence in situ hybridization, and SNP array for the classification of melanocytic neoplasms

  2018cites this paper
• Melanoma

  2018cites this paper
• Gene Expression Profiling for Cutaneous Melanoma

  2018cites this paper
• Developing statistical and bioinformatic analysis of genomic data from tumours

  2018cites this paper
• A machine-learning classifier trained with microRNA ratios to distinguish melanomas from nevi

  2018influential citation
• The Pathology of Melanoma

  2018cites this paper
• Pathologie moléculaire des mélanomes : applications pratiques

  2018cites this paper
• Nevo de Spitz atípico versus melanoma spitzoide: el papel de la hibridación fluorescente in situ en el diagnóstico de lesiones melanocíticas ambiguas.

  2018cites this paper
• Molecular Testing for Cutaneous Melanoma: An Update and Review.

  2018cites this paper
• Appropriate use criteria in dermatopathology: Initial recommendations from the American Society of Dermatopathology

  2018cites this paper
• Review of diagnostic, prognostic, and predictive biomarkers in melanoma

  2018cites this paper
• Significance of epidermal mitoses in challenging melanocytic proliferations

  2017cites this paper
• A Diagnostic Algorithm Combining Immunohistochemistry and Molecular Cytogenetics to Diagnose Challenging Melanocytic Tumors

  2017cites this paper
• Targeted Next-Generation Sequencing Traces the Origin of a Poorly Differentiated Malignancy

  2017cites this paper
• Addressing the challenges of applying precision oncology

  2017cites this paper
• Diagnostic Distinction of Malignant Melanoma and Benign Nevi by a Gene Expression Signature and Correlation to Clinical Outcomes

  2017cites this paper
• Pediatric Melanoma and Atypical Melanocytic Neoplasms.

  2016cites this paper